Memorial Sloan Kettering Partners with Quest for Cancer Dx | GenomeWeb

NEW YORK (GenomeWeb) – Memorial Sloan Kettering Cancer Center has partnered with Quest Diagnostics to use molecular testing of patients' tumors to provide better treatment options and understand the genomic underpinnings of the disease.

In the first phase of the collaboration, Memorial Sloan Kettering will provide contextual information about the mutations identified in a next-generation sequencing-based test developed by Quest and will contribute to the clinical annotation report provided to physicians.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.